beta
VRML
Vermillion, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Market Cap: 390 Million
Primary Exchange: NASDAQ
Website: http://www.vermillion.com
Shares Outstanding: 97.4 Million
Float: 50.6 Million
Dividend: (%)
Beta: 0.6022511223530383
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1769 trading days
From: 2013-05-31 To: 2020-05-29
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|